News Focus
News Focus
icon url

DR Ryan

08/07/14 9:15 AM

#119523 RE: DrBob99 #119520

Welcome Dr. I feel you've discovered ELTP at a great time leading up to many events towards the end of this year. Lots of $ to be made here in the next 12 months, possibly sooner.

I think you'll find this post from Couch sums up why this is such a great investment at this price, both short term and long term.

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=104944647
icon url

Couch

08/07/14 9:16 AM

#119524 RE: DrBob99 #119520

If you go back through Elite's history of trials with Eli 216 - notice they've completed BE studies and human liability studies already. To me it seems with the recent 12hr ART products- the most important studies are the BE studies- as previous human liability studies were positive as mentioned.

Should the FDA not require full scale efficacy trials on the 505b2 products - we've already successfully completed the studies needed- just on separate products.

A good buying opportunity IMO. Good luck on your recent pick up.
icon url

snupoled

08/07/14 9:38 AM

#119527 RE: DrBob99 #119520

Welcom aboard DR.Bob AA?

your in at a great price and at the crossroads of our tiny

speck of a company eltp.

all roads lead to up or down vote with fda

your in before value is added to pps for r+d

your in before launch of 11 generics.

Our ceo is a man of integrity and vision ...read his back ground

He will get the job done! Our ceo could easily run a fortune 500

company, He is not here for our generics and that is a good thing

snup we will all be gleeful on the other side of our sudden news
icon url

dr_lowenstein

08/07/14 12:51 PM

#119556 RE: DrBob99 #119520

"DR", please site precedent for a combo agonist/antagonist that has been approved without a pivotal phase 3 trial , thanks in advance